For the integrated multidisciplinary approach to patient care

Return to the Southern Medical Journal

Current User S2 Access Level: -1 ()
CAN NOT ACCESS LEVEL 2

Pharmacotherapy Considerations in Elderly Adults

James M. Wooten, PharmD
Volume: 105 Issue: 8 August, 2012

Abstract:

Life expectancy for Americans has increased dramatically since 1900, as have the available pharmacotherapeutic options. Unfortunately, pharmacotherapy mishaps occur commonly in the older adult population. This problem greatly affects the morbidity and mortality of elderly patients and greatly increases healthcare costs. To improve patient care among elderly adults, healthcare practitioners must consider several issues when developing a pharmacotherapy plan. A thorough understanding of pharmacokinetics, pharmacodynamics, adverse drug reactions, drug interactions, and several other factors is necessary for practitioners to develop a safe and effective drug therapy plan for older adults. This review provides a general but comprehensive review of the issues pertaining to pharmacotherapy in elderly people and offers several suggestions for improving their pharmaceutical care.

Article:

This content is limited to qualifying members. Please click on an option below to view in full. Click here to compare all member plans.

Login

Silver/Gold members login for full access. Other members login to view purchase options.

Create a New Account

Create a new complimentary account/login to view purchase options.

Images:

This content is limited to qualifying members. Please click on an option below to view in full. Click here to compare all member plans.

Login

Silver/Gold members login for full access. Other members login to view purchase options.

Create a New Account

Create a new complimentary account/login to view purchase options.

References:

1. Turnheim K. Drug therapy in the elderly. Exp Gerontol 2004; 39: 1731–1738.
 
2. Bressler R, Bahl JJ. Principles of drug therapy for the elderly patient. Mayo Clin Proc 2003; 78: 1564–1577.
 
3. Shrestha LB. CRS report for Congress. Life expectancy in the United States. http://aging.senate.gov/crs/aging1.pdf. Accessed February 13, 2012.
 
4. Williams CM. Using medications appropriately in older adults. Am Fam Phys 2002; 66: 1917–1924.
 
5. Wooten J, Galavis J. Polypharmacy: keeping the elderly safe. RN 2005; 68: 44–51.
 
6. Brazeau S. Polypharmacy and the elderly. http://www.stacommunications.com/journals/cme/images/cmepdf/august01/polypharmacyapvd.pdf. Accessed January 20, 2012.
 
7. Drug therapy considerations in older adults. Health Notes 2003; 1: 5–53.
 
8. McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004; 56: 163–184.
 
9. Chaurasia RN, Singh AK, Gambhir IS. Rational drug therapy in elderly. J Indian Acad Geriatr 2005; 2: 82–88.
 
10. Roehl B, Talati A, Parks S. Medication prescribing for older adults. Ann Long-Term Care 2006; 14: 33–39.
 
11. Petrone K, Katz P. Approaches to appropriate drug prescribing for the older adult. Prim Care Clin Office Pract 2005; 32: 755–775.
 
12. American Society of Consultant Pharmacists. ASCP fact sheet. https://www.ascp.com/articles/about-ascp/ascp-fact-sheet. Accessed January 18, 2012.
 
13. Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol 2007; 21: 217–230.
 
14. Hutchison LC, O’Brien CE. Changes in pharmacokinetics and pharmacodynamics in the elderly patient. J Pharm Prac 2007; 20: 4–12.
 
15. Miller SW. Therapeutic drug monitoring in the geriatric patient. In: Murphy JE, ed. Clinical Pharmacokinetics. 4th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2007: chap 23.
 
16. Ferrario CG. Geropharmacology: a primer for advanced practice acute care and critical care nurses, part I. AACN Adv Crit Care 2008; 19: 23–37.
 
17. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004; 57: 6–14.
 
18. Greenblatt DJ, von Moltke LL, Harmatz JS, et al. Pharmacokinetics, pharmacodynamics, and drug disposition. In: Davis KL, Charney D, Coyle JT, et al., eds. Neuropsychopharmacology: The Fifth Generation of Progress. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2002: 507–524.
 
19. Kapadia A, Wynn D, Salzman B. Potential adverse effects of proton pump inhibitors in the elderly. Clin Geriatr 2010; 18: 24–31.
 
20. Richardson MM. Precision versus approximation: the trade off in assessing kidney function and drug dosing. Pharmacotherapy 2010; 30: 758–761.
 
21. Nyman HA, Dowling TC, Hudson JQ, et al. Comparative evaluation of the Cockcroft-Gault equation and the modification of diet in renal disease (MDRD) study equation for drug dosing. Pharmacotherapy 2011; 31: 1130–1144.
 
22. Merle L, Laroche ML, Dantoine T, et al. Predicting and preventing adverse drug reactions in the very old. Drugs Aging 2005; 22: 375–392.
 
23. Routledge PA, O’Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2004; 57: 121–126.
 
24. Gray CL, Gardner C. Adverse drug events in the elderly: an ongoing problem. J Manag Care Pharm 2009; 15: 568–571.
 
25. Snyder S, Pendergraph B. Detection and evaluation of chronic kidney disease. Am Fam Phys 2005; 72: 1723–1734.
 
26. Amarapurkar DN. Prescribing medications in patients with decompensated liver cirrhosis. Int J Hepatol 2011; 11: 1–5.
 
27. Bowie MW, Slattum PW. Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother 2007; 5: 263–303.
 
28. Wang L. Epidemiology and prevention of adverse drug reactions in the elderly. J Geriatr Cardiol 2005; 2: 248–253.
 
29. Mendes-Nett RS, Silva CQ, Oliveira Filho AD, et al. Assessment of drug interactions in elderly patients of a family health care unit in Aracaju (Brazil): a pilot study. Afr J Pharm Pharmacol 2011; 5: 812–818.
 
30. Grattagliano I, Portincasa P, D’Ambrosio G, et al. Avoiding drug interactions: here’s help. J Fam Pract 2010; 59: 322–329.
 
31. Lin P. Drug interactions and polypharmacy in the elderly. Can Alzheimers Dis Rev 2003; 6: 10–14.
 
32. Steinman MA, Handler SM, Gurwitz JH, et al. Beyond the prescription: medication monitoring and adverse drug events in older adults. J Am Geriatr Soc 2011; 59: 1513–1520.
 
33. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012; 10: 1532–1541.
 
34. Baker DW, Wolf MS, Feinglass J, et al. Health literacy and mortality among elderly persons. Arch Intern Med 2007; 167: 1503–1509.
 
35. Weiss BD. Health Literacy and Patient Safety: Help Patients Understand: A Manual for Clinicians. Chicago: American Medical Association; 2007.
 
36. Hamilton H, Gallagher P, Ryan C, et al. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 2011; 171: 1013–1019.

CME:

Portions of this issue may be available for CME credit. Please email education@sma.org for a complete listing of current Southern Medical Journal activities, as well as other SMA educational offerings.

This content is limited to qualifying members. Please click on an option below to view in full. Click here to compare all member plans.

Login

Silver/Gold members login for full access. Other members login to view purchase options.

Create a New Account

Create a new complimentary account/login to view purchase options.

This content is limited to qualifying members. Please click on an option below to view in full. Click here to compare all member plans.

Login

Silver/Gold members login for full access. Other members login to view purchase options.

Create a New Account

Create a new complimentary account/login to view purchase options.

Permissions